Beth H Thompson - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Virus Research|September 13, 2022

1 Cellular protein TTC4 and its cofactor HSP90 are pro-viral for bovine herpesvirus 1Beth H Thompson, Colin P Sharp, Inga R Dry, et al.

RNA (New York, N.Y.)|August 12, 2025

Understanding off-target growth defects introduced to influenza A virus by synonymous recodingColin P Sharp, Beth H Thompson, Ananya Ferdous Hoque, et al.

Plos Pathogens|May 5, 2023

CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategyColin P Sharp, Beth H Thompson, Tessa J Nash, et al.

Wilderness & Environmental Medicine|March 8, 2011

Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group)Buddha Basnyat, Peter S Holck, Matiram Pun, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Virus Research|September 13, 2022

1 Cellular protein TTC4 and its cofactor HSP90 are pro-viral for bovine herpesvirus 1Beth H Thompson, Colin P Sharp, Inga R Dry, et al.

RNA (New York, N.Y.)|August 12, 2025

Understanding off-target growth defects introduced to influenza A virus by synonymous recodingColin P Sharp, Beth H Thompson, Ananya Ferdous Hoque, et al.

Plos Pathogens|May 5, 2023

CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategyColin P Sharp, Beth H Thompson, Tessa J Nash, et al.

Wilderness & Environmental Medicine|March 8, 2011

Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group)Buddha Basnyat, Peter S Holck, Matiram Pun, et al.

Pageof 1